PHIO PHARMACEUTICALS CORP (PHIO) Stock Balance Sheet
USA - NASDAQ:PHIO - US71880W5013 - Common Stock
1.56 USD
+0.08 (+5.41%)
1.5413 USD
-0.02 (-1.2%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 10.78M | 5.38M | 8.49M | 11.78M | 24.06M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | null | null | null | null | null | |||
| Receivables | null | null | null | null | null | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | 519.00K | 354.00K | 832.00K | 670.00K | 670.00K | |||
| Total Current Assets | 11.29M | 5.74M | 9.32M | 12.45M | 24.73M | |||
| Non-Current Assets | ||||||||
| PPE Net | 7.00K | 2.00K | 39.00K | 340.00K | 420.00K | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | null | null | null | null | null | |||
| Other Non-Current Assets | null | 0 | 3.00K | 20.00K | 30.00K | |||
| Total Non-Current Assets | 7.00K | 2.00K | 42.00K | 360.00K | 440.00K | |||
| TOTAL ASSETS | 11.30M | 5.74M | 9.36M | 12.81M | 25.17M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | null | null | null | null | null | |||
| Accrued Expenses | 971.00K | 762.00K | 977.00K | 1.16M | 2.79M | |||
| Accounts Payable | 235.00K | 253.00K | 657.00K | 780.00K | 280.00K | |||
| Other Current Liabilities | null | null | null | null | null | |||
| Total Current Liabilities | 1.21M | 1.01M | 1.63M | 1.94M | 3.07M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | null | null | 0 | 30.00K | 170.00K | |||
| Total Non-Current Liabilities | 0 | 0 | 0 | 30.00K | 170.00K | |||
| TOTAL LIABILITIES | 1.21M | 1.01M | 1.63M | 1.97M | 3.24M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -150.29M | -146.36M | -139.21M | -128.38M | -116.90M | |||
| Additional Paid In Capital | 160.39M | 151.08M | 146.94M | 139.22M | 138.83M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 500 | 200 | 400 | 0 | 0 | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | -500 | -200 | -400 | null | null | |||
| Shares Outstanding | 4.80M | 1.73M | 416.40K | 1.14M | 1.13M | |||
| Tangible Book Value per Share | 2.1039 | 2.7242 | 18.5652 | 9.5088 | 19.4071 | |||
| Total Shareholders' Equity | 10.10M | 4.72M | 7.73M | 10.84M | 21.93M | |||
| TOTAL LIABILITIES AND EQUITY | 11.30M | 5.74M | 9.36M | 12.81M | 25.17M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 9.36 | 5.65 | 5.71 | 6.42 | 8.06 | |||
| Return On Assets (ROA) | -62.69% | -124.61% | -117.47% | -89.62% | -52.80% | |||
| Return On Equity (ROE) | -70.18% | -151.39% | -142.30% | -105.90% | -60.60% | |||
All data in USD , ROIC based on taxRate of 0.21